Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

Divekar, Abhay A.; Arar, Yousef M.; Clark, Stephen; Tandon, Animesh; Zellers, Thomas M.; Veeram Reddy, Surendranath R.

doi:10.3390/children9040497

Open AccessReview

Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

by

Abhay A. Divekar

^1,2,*

,

Yousef M. Arar

^1,2,

Stephen Clark

^1,2,

Animesh Tandon

³

,

Thomas M. Zellers

^1,2

and

Surendranath R. Veeram Reddy

^1,2

¹

Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA

²

Pediatric Cardiology, Children’s Medical Center, 1935 Medical District Drive, Dallas, TX 75235, USA

³

Department of Pediatric Cardiology, Cleveland Clinic Children’s Hospital, Cleveland, OH 44195, USA

^*

Author to whom correspondence should be addressed.

Children 2022, 9(4), 497; https://doi.org/10.3390/children9040497

Submission received: 1 February 2022 / Revised: 27 March 2022 / Accepted: 29 March 2022 / Published: 2 April 2022

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Congenital Heart Disease in Children)

Download

Browse Figures

Review Reports Versions Notes

Abstract

Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use of devices is common and appropriate, a growing number of devices are now specifically designed and approved for use in CHD. Advanced imaging is now an integral part of interventional procedures including pre-procedure planning, intra-procedural guidance, and post-procedure monitoring. There is robust societal and industrial support for research and development of CHD-specific devices, and the regulatory framework at the national and international level is patient friendly. It is against this backdrop that we review transcatheter implantable devices for CHD, the role and integration of advanced imaging, and explore the current regulatory framework for device approval.

Keywords: congenital heart disease; transcatheter intervention; cross-sectional imaging; stents; transcatheter pulmonary valve implantation; Septal Occluders

Share and Cite

MDPI and ACS Style

Divekar, A.A.; Arar, Y.M.; Clark, S.; Tandon, A.; Zellers, T.M.; Veeram Reddy, S.R. Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease. Children 2022, 9, 497. https://doi.org/10.3390/children9040497

AMA Style

Divekar AA, Arar YM, Clark S, Tandon A, Zellers TM, Veeram Reddy SR. Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease. Children. 2022; 9(4):497. https://doi.org/10.3390/children9040497

Chicago/Turabian Style

Divekar, Abhay A., Yousef M. Arar, Stephen Clark, Animesh Tandon, Thomas M. Zellers, and Surendranath R. Veeram Reddy. 2022. "Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease" Children 9, no. 4: 497. https://doi.org/10.3390/children9040497

APA Style

Divekar, A. A., Arar, Y. M., Clark, S., Tandon, A., Zellers, T. M., & Veeram Reddy, S. R. (2022). Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease. Children, 9(4), 497. https://doi.org/10.3390/children9040497

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI